These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18419547)

  • 41. The Burden of Human Papillomavirus and Chlamydia trachomatis Coinfection in Women: A Large Cohort Study in Inner Mongolia, China.
    Ji Y; Ma XX; Li Z; Peppelenbosch MP; Ma Z; Pan Q
    J Infect Dis; 2019 Jan; 219(2):206-214. PubMed ID: 30192954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study.
    Učakar V; Poljak M; Klavs I
    Vaccine; 2012 Jan; 30(2):116-20. PubMed ID: 22080175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain.
    García-Espinosa B; Moro-Rodríguez E; Alvarez-Fernández E
    BMC Cancer; 2012 Nov; 12():533. PubMed ID: 23167826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of human papillomavirus in women from Saudi Arabia.
    Turki R; Sait K; Anfinan N; Sohrab SS; Abuzenadah AM
    Asian Pac J Cancer Prev; 2013; 14(5):3177-81. PubMed ID: 23803100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.
    Giorgi Rossi P; Bisanzi S; Paganini I; Di Iasi A; Angeloni C; Scalisi A; Macis R; Pini MT; Chini F; Carozzi FM;
    BMC Infect Dis; 2010 Jul; 10():214. PubMed ID: 20646310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.
    Zhang C; Cheng W; Liu Q; Guan Q; Zhang Q
    Virol J; 2019 May; 16(1):67. PubMed ID: 31109361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico.
    Parada R; Morales R; Giuliano AR; Cruz A; Castellsagué X; Lazcano-Ponce E
    BMC Infect Dis; 2010 Jul; 10():223. PubMed ID: 20667085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.
    Tota JE; Jiang M; Ramanakumar AV; Walter SD; Kaufman JS; Coutlée F; Richardson H; Burchell AN; Koushik A; Mayrand MH; Villa LL; Franco EL
    PLoS One; 2016; 11(12):e0166329. PubMed ID: 28005904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study.
    Orlando G; Fasolo M; Mazza F; Ricci E; Esposito S; Frati E; Zuccotti GV; Cetin I; Gramegna M; Rizzardini G; Tanzi E;
    Hum Vaccin Immunother; 2014; 10(4):986-94. PubMed ID: 24423757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology.
    Orozco-Colín A; Carrillo-García A; Méndez-Tenorio A; Ponce-de-León S; Mohar A; Maldonado-Rodríguez R; Guerra-Arias R; Flores-Gil O; Sotelo-Regil R; Lizano M
    Int J Infect Dis; 2010 Dec; 14(12):e1082-7. PubMed ID: 20952235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India.
    Menezes LJ; Poongulali S; Tommasino M; Lin HY; Kumarasamy N; Fisher KJ; Saravanan S; Gheit T; Ezhilarasi C; Jeeva A; Lu B; Giuliano AR
    Int J STD AIDS; 2016 Jun; 27(7):543-53. PubMed ID: 26002318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
    Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
    BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and genotype distribution of human papillomavirus in non-neoplastic cervical tissue lesion: cervical erosion.
    Bayram A; Erkılıç S; Balat Ö; Ekşi F; Uğur MG; Öztürk E; Kaya G
    J Med Virol; 2011 Nov; 83(11):1997-2003. PubMed ID: 21915876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
    Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
    J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of human papillomavirus infection among 71,435 women in Jiangxi Province, China.
    Zhong TY; Zhou JC; Hu R; Fan XN; Xie XY; Liu ZX; Lin M; Chen YG; Hu XM; Wang WH; Li L; Xiao HP
    J Infect Public Health; 2017; 10(6):783-788. PubMed ID: 28214188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.